Life Science Leader Magazine Supplements

CMO 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/792774

Contents of this Issue

Navigation

Page 54 of 81

K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 53 CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY QUALITY 2017 CMO LEADERSHIP AWARDS WINNERS Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Production SERVICES & CAPABILITIES: aseptic fill/finish, generics, injectables, liquids, lyophilized products, non-sterile, parenterals: large volume, parenterals: small volume, proteins, solutions & suspensions, sterile, syringes: pre-filled, vaccines, DNA, viruses, microbiota, fill finish, cell line development, cell banking, stability testing, protein characterization, bioassays, analytical services, sterile drug product fill & finish "I am delighted that Cobra has been selected for a CMO Leadership Award. I believe our global repu- tation in the market for excellent science and GMP manufacture, along with a close rapport with our growing customer base, are the reasons behind our rapid growth over the last 5 years as we aim to become a global leader in biologics contract manufacturing." DRUG TYPE: Biopharmaceuticals PETER COLEMAN CEO CATEGORIES WON: Cobra Biologics Keele Science Park, Newcastle under Lyme, UK www.cobrabio.com Phone: +44 (0)1782 714181 Contact: Jason Rahal Email: jason.rahal@cobrabio.com Key locations: Newcastle under Lyme, UK; Soder- talje, Sweden; Matfors, Sweden INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre- Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, cartridges, injectables, liquids, lyophilized prod- ucts, parenterals: large volume, parenterals: small volume, peptides, proteins, solutions & suspen- sions, sterile, syringes: pre-filled, vaccines, devel- opment, bulk drug substance, parenteral drug product, secondary packaging "At Cook Pharmica, we take pride in helping develop and deliver life-enhancing biopharma- ceuticals to patients around the world. Through time, our team has had the pleasure of assisting our clients in developing and manufacturing truly amazing products. We are humbled that our clients continue to value the work we perform. And, we appreciate the favorable acknowledge- ment by these clients, as recognized via the CMO Leadership Awards." DRUG TYPE: Pharmaceuticals, Biopharmaceuticals TEDD GREEN President CATEGORIES WON: Cook Pharmica Bloomington, IN www.cookpharmica.com Phone: +1 877 312 2665 Contact: Cory Lewis Email: busdev@cookpharmica.com Key locations: Bloomington, IN INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, capsules, cartridges, controlled substances, cyto- toxic & high potency compounds, generics, inject- ables, liquids, lyophilized products, non-sterile, parenterals: large volume, parenterals: small volume, peptides, powders: non-sterile, powders: sterile, proteins, solid dose, solutions & suspen- sions, sterile, syringes: pre-filled "We are honored to receive the Life Science Leader 2017 CMO Leadership Awards across all six core categories, recognized by small and large pharma customers. Organized under five technology plat- forms, CordenPharma experts are committed to full-service supply as a CDMO partner to the global pharmaceutical industry. These awards from our customers reflect our continuing drive to expand upon existing capabilities in order to provide cost- effective, integrated solutions for their complete contract development and manufacturing needs." DRUG TYPE: Pharmaceuticals ERNESTO PETROSELLI President CATEGORIES WON: CordenPharma Plankstadt Germany www.cordenpharma.com/contact-us/ Phone: +1 800 868 8208 Email: sales@cordenpharma.com Key locations: Colorado, USA; Caponago, IT; Latina, IT; Plankstadt, DE; Bergamo, IT; Brussels, BE; Switzerland; ChenĂ´ve, FR INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2017